HiveProspectStranded Biotech Asset IntelligenceResearch intelligence
Research workspace tools

Cotrifazid vs mefloquine or quinine+SP

TERMINATED · PHASE2 · Clinical Malaria

Unknown stopping reason

Registry source

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.